Medicaid members respond to refill reminder in double digits

February 1, 2020

First (known) study of Medicaid member refill letter improves refill rates 14% to 18% for chronic conditions

This study assessed the impact of a member letter campaign on refill rates among Medicaid members for three chronic conditions: depression, oral diabetes drugs and asthma. Prime and Health Care Services Corporation (HCSC) found that letters drove a 14-18% higher rate of refilled prescriptions in all three chronic drug therapy categories. Results were compared to a randomized control group.

The program had a compact timeline for contacting members. Letters were mailed to members if seven or more days had lapsed since their prescription supply ended. Member files were pulled weekly. 

This is the first study of its kind assessing the impact of a refill reminder letter from a health insurer to Medicaid members. Study planners originally thought address quality might be an issue; but only 0.5% of missed refill member mailings were returned to sender. This meant the database of addresses for the population was reliable. The Academy of Managed Care Pharmacy (AMCP) recognized this research with a gold award.

Medicaid Missed Refill Letter Intervention Impact on Refill Rate versus Randomized Control (Spring 2019)

Related news

Perspectives

April 17, 2024

AMCP 2024: Behind the research with YuQian Liu

Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of this exciting frontier

Perspectives

April 16, 2024

AMCP 2024: Behind the research with Jacob LaRue and Timothy O’Shea

Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty drugs without therapeutic impact to patients

Perspectives

April 15, 2024

Oncology Insights: Cancer treatment is personal

Precision medicine, or personalized medicine, uses genes or proteins to diagnose or treat disease. This medical care design has significantly impacted oncology and grew out of a need to improve and individualize patient treatments